Pfiz­er plans $465M man­u­fac­tur­ing fa­cil­i­ty at Michi­gan base; Chi­na's Ts­inghua Uni­ver­si­ty inks dis­cov­ery deal with Bris­tol-My­ers

→ Re­cent­ly bat­tling some trou­bling short­ages in ster­ile in­jecta­bles, Pfiz­er $PFE an­nounced it’s step­ping up its man­u­fac­tur­ing game by spend­ing $465 mil­lion on …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.